 That's what we see in these studies. The dropout rate is higher in the control group and so forth. And that makes any inferences really difficult from a study like this. And that is why I was so surprised that MAPS even went with this study design, because mathematically speaking, it's not a very sound design in a situation where we know that folks will not be blind to their treatment allocation.